Full-Life Technologies|Home

Full-Life Technologies|Home

Private
Shanghai, ShanghaiHealthcare & Life Scienceswww.full-life.com

Last Round

Series D

May 18, 2026

Total Funding Raised

$297.3M

Company Overview

Full-Life Technologies is a healthcare company specializing in targeted cancer therapy services within the radiotherapy field, dedicated to advancing nuclear medicine to enhance treatment outcomes for cancer patients through innovative radiopharmaceutical research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radiopharmaceuticalsradionuclide drug conjugatesRDCsradiotherapeuticsradiopharmatargeted radiotherapyradioligand therapyradiopharmaceutical manufacturingActinium-225Ac-225CDMOcontract development and manufacturing organizationnuclear medicinedrug discovery platformlinker technologyPSMA-targeted therapyprostate cancer treatmentmCRPCdrug licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Full-Life Technologies|Home Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Full-Life Technologies|Home Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DMay 18, 2026
DebtSep 29, 2025
Series CSep 29, 2025
Series BJan 3, 2024
DebtJan 3, 2024
Series A
May 26, 2022

Key People

Founding team and executive leadership

Nicholas Chung Lim Wong

COO And Co-founder

Founding Team

Lanny Sun

Chairman & CEO

Executive Team

Full-Life Technologies|Home Investors

Notable investors and investment history

InvestorRounds
CD Capital Asset ManagementSeries A
Summer CapitalSeries C, Series B
Guanghua Wutong FundSeries B
Junson CapitalSeries D, Series C, Series A, Series B
Lapam CapitalSeries C
Yunion Health InvestmentsSeries A
Sky9 CapitalSeries D, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    $110M round led by Vivo Capital.

  • Apr 1, 2026

    Job posting reveals development of c-MET assets.

Full-Life Technologies|Home Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Full-Life Technologies|Home Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Full-Life Technologies|Home's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai, Shanghai
Employee Range60
Year Founded2021
Last FundingMay 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.